Eli Lilly Abandons Development of New Cholesterol Drug after Poor Performance in Phase 3 Trial
A Cholesterol Drug Fail To Perform Well. On Monday, drug maker Eli Lilly announced that it was ceasing work on a new cholesterol-lowering drug, after the drug failed to perform well in a phase 3 clinical trial. The drug, evacetrapib, was designed to prevent heart attacks and other cardiovascular problems by modifying cholesterol … [Read more...]
Eli Lilly Abandons Development of New Cholesterol Drug
Eli Lilly Ceased Work For New Cholesterol Drug. Drug maker Eli Lilly announced that it was ceasing work on a new cholesterol-lowering drug, after the drug failed to perform well in a phase 3 clinical trial. The drug, evacetrapib, was designed to prevent heart attacks and other cardiovascular problems by modifying cholesterol … [Read more...]
Philippine FDA Announces Two Drug Recalls
The Philippine FDA Two Drug Recalls. The Food and Drug Administration (FDA) of the Philippines, in two separate advisories, has recalled specific lots and batches of two drug products: a cholesterol-lowering drug, and a drug used in the treatment of tuberculosis and other infections. In its advisories, the Philippine regulatory … [Read more...]
Vytorin Probe Seeks Information
Vytorin Probe Seeks Information. Lawmakers investigating the cholesterol drug Vytorin have asked Merck and Schering-Plough for more information on the medication's clinical trials. According to Reuters, Rep. Henry Waxman (D-Calif), chairman of the House Energy and Commerce Committee, has written two companies on Thursday seeking … [Read more...]
Vytorin Confusion Leaves Patients Wondering
Vytorin Confusion Leaves Patients Wondering. Many patients - and probably some doctors - are scratching their heads over Vytorin. Though it has been on the market for four years, little is known about its safety and effectiveness. This year, two studies - ENHANCE and SEAS - have only added to the confusion over the cholesterol … [Read more...]
Another Vytorin Failure
Another Vytorin Failure. Yesterday's news that Vytorin failed to meet the primary endpoint in another important study has not done much to restore faith in the controversial cholesterol drug. First shown to be ineffective in preventing clogged arteries, it now seems Vytorin does little to help patients with aortic stenosis avoid … [Read more...]
Call for Withdrawal of Cholesterol Drug
Cholesterol Drug Crestor Can Cause Kidney Damage. A leading consumer watchdog group issued a new warning Friday about the cholesterol-lowering drug Crestor, alleging that patients who use it are 75 times likelier to suffer kidney damage than are patients using any other statin. Public Citizen has been urging the U.S. Food and Drug … [Read more...]
Nearly $1.1B Bayer Settlements
Bayer Settlements Over Pulled Cholesterol Drug. Drug maker Bayer AG said Monday it has reached settlements in more than 2,800 cases related to the 2001 withdrawal of a cholesterol-lowering drug, paying nearly $1.1 billion in out-of-court deals. ‘Bayer’ pulled Lipobay, marketed as Baycol in the United States, after it was linked to … [Read more...]
More Illnesses to Cholesterol Drug
Illnesses Tied To Cholesterol Drug Crestor. A consumer health group, citing mounting cases of severe illness tied to the cholesterol-lowering drug Crestor, has taken its call for a ban on the pill to the pages of a leading medical journal. "To allow AstraZeneca to continue desperately seeking a piece of the estimated $20 … [Read more...]
E-mails Put Bayer on the Spot
Bayer Cholesterol Drug On The Spot. Some Bayer officials were worried about growing reports of deaths associated with the company's anti-cholesterol drug 18 months before it was pulled from the market, newly disclosed company documents show. ''So much for keeping this quiet,'' Patricia Stenger, a manager in Bayer's scientific … [Read more...]
The First Baycol Trial Opens
Baycol May Cause Health Problems. Attorneys for a man who claims a cholesterol drug caused his health to deteriorate accused its manufacturer of pushing through an unsafe drug to maximize profits. Opening arguments began Thursday in a lawsuit against Bayer Pharmaceutical Co. over its recalled drug Baycol. At issue is the company's … [Read more...]
Local Residents Learn Effects of Cholesterol Drug
Cholesterol Drug Side Effects. Virginia Parrish ended up in the hospital about two months after she started taking a new cholesterol drug in 2000, but doctors were unable to diagnose what caused the weakness that left her unable to stand. Parrish, 80, said she suffered from muscle pain, weakness and a variety of other symptoms for … [Read more...]
Bayer Legal Action Over Baycol Gathers Pace in US
Baycol Has Been Linked To Deaths. Bayer, of Germany, is facing an escalation of its legal problems as lawyers from more than 50 US firms gather in Chicago on Wednesday to co-ordinate their actions over Baycol, the cholesterol drug. The troubled chemicals and pharmaceuticals group also faces an investigation by the state prosecutor … [Read more...]
